Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
104 participants
INTERVENTIONAL
2021-02-28
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improved Outcomes With Pre-Procedure Shockwave IVL of Common Femoral Artery Access Site Prior to Large Bore Access and Pre-Closure
NCT07205068
Prevention of Radial Artery Occlusion After Trans-radial Cardiac Catheterization
NCT03182530
Radial Artery Occlusion and Dual Artery Hemostasis After Transradial Approach.
NCT04933136
Assessment of Distal Protection Device in Patients at High Risk for Distal Embolism in Acute Coronary Syndrome (ACS)
NCT01460966
Feasibility and Safety of Total Percutaneous Closure of Femoral Arterial Access Sites in the Veno-arterial ECMO Patients
NCT04689451
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
Femoral access using 3D US
3D US
3D US guided access to femoral artery
Control
Femoral access using 2D US
2D US
2D US guided access to femoral artery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
3D US
3D US guided access to femoral artery
2D US
2D US guided access to femoral artery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Scheduled to undergo elective transcatheter aortic valve implantation with percutaneous access through the femoral artery
* Written Informed consent
Exclusion Criteria
* Vascular access via alternative approach (radial/subclavian) or surgical cutdown
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eindhoven University of Technology
OTHER
Catharina Ziekenhuis Eindhoven
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Harm Scholten
md
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Catharina Ziekenhuis Eindhoven
Eindhoven, North Brabant, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
3D-US-TAVI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.